ArticleHepatology international2024

The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.

Zhen-Xin Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.